O-Methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and Low MGMT-Encoded Protein Expression as Prognostic Markers in Glioblastoma Patients Treated With Biodegradable Carmustine Wafer Implants After Initial Surgery Followed by Radiotherapy With Concomitant and Adjuvant Temozolomide
暂无分享,去创建一个
M. Bernaudin | F. Chapon | M. Diebold | A. Vital | P. Menei | J. Guillamo | P. Colin | A. Dugué | É. Emery | G. Levallet | E. Lechapt-Zalcman | Philippe Peruzzy